Literature DB >> 24390754

microRNA expression and its potential role in cardioprotection by ischemic postconditioning in pigs.

Theodor Baars1, Andreas Skyschally, Ludger Klein-Hitpass, Elke Cario, Raimund Erbel, Gerd Heusch, Petra Kleinbongard.   

Abstract

Ischemic postconditioning (PoCo) reduces infarct size following myocardial ischemia/reperfusion. To protect, PoCo must be performed early during reperfusion, and causal cardioprotective signaling must occur then. The role of microRNA (miRNA) in PoCo is unclear. Anesthetized pigs were subjected to 60 min left anterior descending coronary artery (LAD) occlusion and 180 min reperfusion. Immediate full reperfusion (IFR, n = 5) was compared to PoCo (four cycles of 60 s/60 s reperfusion/reocclusion, n = 5). Transmural myocardial biopsies from the LAD territory were sampled at baseline, 60 min ischemia, 10 and 180 min reperfusion. RNA was isolated. The expression of 11 miRNAs, including muscle-specific (miRNA-1, -133a, -206, -208b, -214, and -499), fibrosis- (miRNA-21, -24, and -29b), neovascularization- (miRNA-92a), and inflammation-associated (miRNA-146b) candidates, was quantified using real-time PCR (RT-PCR). mRNA expression at baseline and 180 min reperfusion was quantified and validated (microarray and RT-PCR). PoCo reduced infarct size from 44.9 ± 7.7 to 34.8 ± 5.3% of the area at risk. The expression of miRNA-1, -24, -29b, -133a, -146b, -208b, and -499 was increased at 10 min reperfusion with PoCo vs. IFR; however, that of miRNA-1, -24, -208b, and -499 was already increased at 60 min ischemia and probably reflects falsely positive results. Five mRNAs were different with PoCo vs. IFR. In silico analysis identified a tentative connection between three miRNAs and five mRNAs with the biological functions "cell death", "inflammatory response" and/or "glucose metabolism". If at all, only miRNA-29b, -133a, and -146b fulfill the minimal temporal requirements for a potential causal involvement in cardioprotection by PoCo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390754     DOI: 10.1007/s00424-013-1429-3

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  47 in total

1.  Postconditioning: old wine in a new bottle?

Authors:  Gerd Heusch
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

Review 2.  Control of cardiovascular differentiation by microRNAs.

Authors:  Kisho Ohtani; Stefanie Dimmeler
Journal:  Basic Res Cardiol       Date:  2010-12-24       Impact factor: 17.165

Review 3.  Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

Authors:  Michel Ovize; Gary F Baxter; Fabio Di Lisa; Péter Ferdinandy; David Garcia-Dorado; Derek J Hausenloy; Gerd Heusch; Jakob Vinten-Johansen; Derek M Yellon; Rainer Schulz
Journal:  Cardiovasc Res       Date:  2010-05-06       Impact factor: 10.787

4.  MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction.

Authors:  Emanuela Bostjancic; Nina Zidar; Dusan Stajer; Damjan Glavac
Journal:  Cardiology       Date:  2009-12-21       Impact factor: 1.869

5.  MicroRNAs in ischemia-reperfusion injury.

Authors:  Jakob Bw Weiss; Steffen U Eisenhardt; G Björn Stark; Christoph Bode; Martin Moser; Sebastian Grundmann
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

6.  Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.

Authors:  Guohu Li; Fausto Labruto; Allan Sirsjö; Fei Chen; Jarle Vaage; Guro Valen
Journal:  Eur J Cardiothorac Surg       Date:  2004-11       Impact factor: 4.191

7.  Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart.

Authors:  C Li; W Browder; R L Kao
Journal:  Am J Physiol       Date:  1999-02

8.  Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.

Authors:  Rabea Hinkel; Daniela Penzkofer; Stefanie Zühlke; Ariane Fischer; Wira Husada; Quan-Fu Xu; Elisabeth Baloch; Eva van Rooij; Andreas M Zeiher; Christian Kupatt; Stefanie Dimmeler
Journal:  Circulation       Date:  2013-07-29       Impact factor: 29.690

9.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

10.  Plasma lysosomal enzyme activity in acute myocardial infarction and the effects of drugs.

Authors:  E Welman; J F Colbeck; A P Selwyn; K M Fox; I Orr
Journal:  Adv Myocardiol       Date:  1980
View more
  10 in total

1.  At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.

Authors:  Defeng Pan; Dongye Li
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

Review 3.  Cardioprotection by remote ischemic conditioning and its signal transduction.

Authors:  Petra Kleinbongard; Andreas Skyschally; Gerd Heusch
Journal:  Pflugers Arch       Date:  2016-12-07       Impact factor: 3.657

4.  A Nomogram model for predicting the occurrence of no-reflow phenomenon after percutaneous coronary intervention using the lncRNA TUG1/miR-30e/NPPB biomarkers.

Authors:  Chen-Kai Hu; Ru-Ping Cai; Lei He; Shi-Rong He; Jun-Yu Liao; Qiang Su
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

5.  microRNA-144: the 'what' and 'how' of remote ischemic conditioning?

Authors:  Karin Przyklenk
Journal:  Basic Res Cardiol       Date:  2014-07-31       Impact factor: 17.165

6.  Ginsenoside-Rb1 Protects Hypoxic- and Ischemic-Damaged Cardiomyocytes by Regulating Expression of miRNAs.

Authors:  Xu Yan; Jinrong Xue; Hongjin Wu; Shengqi Wang; Yuna Liu; Sidao Zheng; Chengying Zhang; Cui Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

7.  Gene expression profiling analysis to investigate the role of remote ischemic postconditioning in ischemia-reperfusion injury in rats.

Authors:  Zanxin Wang; Junmin Wen; Chuzhi Zhou; Zhiwei Wang; Minxin Wei
Journal:  BMC Genomics       Date:  2019-05-09       Impact factor: 3.969

Review 8.  Post-Genomic Methodologies and Preclinical Animal Models: Chances for the Translation of Cardioprotection to the Clinic.

Authors:  Lina Badimon; Guiomar Mendieta; Soumaya Ben-Aicha; Gemma Vilahur
Journal:  Int J Mol Sci       Date:  2019-01-25       Impact factor: 5.923

9.  Apoptosis-related microRNA changes in the right atrium induced by remote ischemic perconditioning during valve replacement surgery.

Authors:  Qinghua Hu; Wanjun Luo; Lingjin Huang; Rimao Huang; Ri Chen
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

10.  Temporally Altered miRNA Expression in a Piglet Model of Hypoxic Ischemic Brain Injury.

Authors:  Sophie Casey; Kate Goasdoue; Stephanie M Miller; Gary P Brennan; Gary Cowin; Adam G O'Mahony; Christopher Burke; Boubou Hallberg; Geraldine B Boylan; Aideen M Sullivan; David C Henshall; Gerard W O'Keeffe; Catherine Mooney; Tracey Bjorkman; Deirdre M Murray
Journal:  Mol Neurobiol       Date:  2020-07-27       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.